- CH₣4.29bn
- CH₣4.76bn
- CH₣3.07bn
- 96
- 35
- 81
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,782 | 1,707 | 1,897 | 2,739 | 3,073 |
Cost of Revenue | |||||
Gross Profit | 1,137 | 1,061 | 1,232 | 1,573 | 1,740 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,546 | 1,480 | 1,596 | 2,408 | 2,714 |
Operating Profit | 236 | 227 | 302 | 330 | 359 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 230 | 220 | 302 | 338 | 352 |
Provision for Income Taxes | |||||
Net Income After Taxes | 207 | 185 | 248 | 271 | 269 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 205 | 184 | 244 | 267 | 266 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 205 | 184 | 244 | 267 | 266 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.47 | 4.81 | 6.39 | 6.91 | 6.78 |
Dividends per Share |